David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA

home / authors / david-e-koren-pharmd-mph-bcps-aahivp-fidsa

Koren is a pharmacist specialist at Temple University health system and adjunct assistant clinical professor at the Lewis Katz School of Medicine at Temple University in Philadelphia, PA.

Articles

An Update on Lenacapavir

An Update on Lenacapavir

T. Sam Albanesi, MD, MA;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
June 9th 2023

This new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.

Read More

Preparing for the Next Long-acting Antiretrovirals

Preparing for the Next Long-acting Antiretrovirals

Valencia Oglesby, DO;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
December 27th 2022

Clinicians can make room for infrequent treatment options as patients enjoy their daily lives.

Read More

Site Logo

How Close Are We to a Cure for HIV?

Della Xu, PharmD;David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA
June 11th 2020

Evolving research has led the infectious diseases community to redefine its definition of cure.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
Published: November 18th 2024 | Updated: November 21st 2024
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients
Published: November 18th 2024 | Updated: November 21st 2024
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients
Challenges of Treating Patients With Staphylococcus aureus
Published: November 18th 2024 | Updated: November 21st 2024
Challenges of Treating Patients With Staphylococcus aureus
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Published: November 10th 2024 | Updated: November 21st 2024
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Echinocandin Dosing Considerations in Obese Patients: A Review
Published: November 18th 2024 | Updated: November 18th 2024
Echinocandin Dosing Considerations in Obese Patients: A Review
© 2024 MJH Life Sciences

All rights reserved.